e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF
F. Drakopanagiotakis, A. Xyfteri, E. Tsiambas, G. Vilaras, A. Karameris, C. Tsakanika, V. Polychronopoulos, D. Bouros (Athens, Alexandroupoli, Greece)
Source:
Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Session:
Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Session type:
Poster Discussion
Number:
4777
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Drakopanagiotakis, A. Xyfteri, E. Tsiambas, G. Vilaras, A. Karameris, C. Tsakanika, V. Polychronopoulos, D. Bouros (Athens, Alexandroupoli, Greece). Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF. Eur Respir J 2011; 38: Suppl. 55, 4777
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001
Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007
Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
No evidence of corticosteroid resistance in COPD alveolar macrophages
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
PD-L1 expression on alveolar macrophages and in plasma of IPF patients – original research
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
IFNγ induces steroid unresponsiveness in smokers alveolar macrophages
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Source: Eur Respir J 2006 Oct 01;28(4):824-831
Year: 2006
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 502s
Year: 2002
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept